Skip to content

Skin barrier function test and analysis of healthy children and autistic children and the effect of CureCode Double Barrier Cream on skin barrier function and autism rating scale score of autistic children

Skin barrier function test and analysis of healthy children and autistic children and the effect of CureCode Double Barrier Cream on skin barrier function and autism rating scale score of autistic children

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053096
Enrollment
Unknown
Registered
2021-11-10
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy children and autistic children

Interventions

Intervention group:External apply CureCode Double Barrier Cream
Non-treatment intervention group:None

Sponsors

The First Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 6 Years

Inclusion criteria

Inclusion criteria: Healthy children: 1.Healthy preschoolers aged 3 to 6 years; 2.No skin lesions on both forearms. Autistic children: 1.Patients with autism spectrum disorders diagnosed by child psychiatrists, developmental pediatricians, child psychotherapists or child therapists, and meeting the diagnostic criteria of DSM-5; 2.Diagnose was verified according to CARS-2; 3.Preschool children aged 3 to 6 years; 4.There were no significant changes in behavior or medical treatment in the past two months, and no changes were planned for the next two months of the study.

Exclusion criteria

Exclusion criteria: Healthy children: Diagnosed as atopic dermatitis (AD) or other skin diseases involving the whole body. Autistic children: 1.Diagnosed with other mental disorders, including attention deficit hyperactivity disorder (ADHD), compulsion, anxiety, depression, etc.; 2.Diagnosed with organic brain injury, epilepsy, or other neurological diseases; 3.Patients with skin lesions on both forearms, diagnosed as atopic dermatitis (AD), or allergic history to cosmetic ingredients.

Design outcomes

Primary

MeasureTime frame
Transepidermal water loss, TEWL;Stratum corneum hydration, SCH;Skin surface pH;

Secondary

MeasureTime frame
Childhood Autism Rating Scale (CARS) Score;Autism Treatment Evaluation Checklist (ATEC) Score;Autism Behavior Checklist (ABC) Score;Social Responsiveness Scale (SRS) Score;Repetitive Behavior Scale-Revised (RBS-R) Score;

Countries

China

Contacts

Public ContactZhang Guoqiang

The First Hospital of Hebei Medical University

zgq810328@sina.com+86 18633888122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026